Marshall Institute for Interdisciplinary Research, Marshall University, Huntington, West Virginia.
Blood Research Institute, Versiti, Milwaukee, Wisconsin.
Am J Physiol Cell Physiol. 2020 Dec 1;319(6):C1107-C1119. doi: 10.1152/ajpcell.00083.2020. Epub 2020 Sep 30.
We have reported that the reduction in plasma membrane cholesterol could decrease cellular Na/K-ATPase α1-expression through a Src-dependent pathway. However, it is unclear whether cholesterol could regulate other Na/K-ATPase α-isoforms and the molecular mechanisms of this regulation are not fully understood. Here we used cells expressing different Na/K-ATPase α isoforms and found that membrane cholesterol reduction by U18666A decreased expression of the α1-isoform but not the α2- or α3-isoform. Imaging analyses showed the cellular redistribution of α1 and α3 but not α2. Moreover, U18666A led to redistribution of α1 to late endosomes/lysosomes, while the proteasome inhibitor blocked α1-reduction by U18666A. These results suggest that the regulation of the Na/K-ATPase α-subunit by cholesterol is isoform specific and α1 is unique in this regulation through the endocytosis-proteasome pathway. Mechanistically, loss-of-Src binding mutation of A425P in α1 lost its capacity for regulation by cholesterol. Meanwhile, gain-of-Src binding mutations in α2 partially restored the regulation. Furthermore, through studies in caveolin-1 knockdown cells, as well as subcellular distribution studies in cell lines with different α-isoforms, we found that Na/K-ATPase, Src, and caveolin-1 worked together for the cholesterol regulation. Taken together, these new findings reveal that the putative Src-binding domain and the intact Na/K-ATPase/Src/caveolin-1 complex are indispensable for the isoform-specific regulation of Na/K-ATPase by cholesterol.
我们曾报道,质膜胆固醇的减少可通过Src 依赖途径降低细胞 Na/K-ATPaseα1 表达。然而,胆固醇是否能调节其他 Na/K-ATPaseα 同工型以及这种调节的分子机制尚不清楚。在此,我们利用表达不同 Na/K-ATPaseα 同工型的细胞发现,U18666A 降低膜胆固醇可减少α1 同工型的表达,但不减少α2 或α3 同工型的表达。成像分析显示α1 和α3 发生细胞内再分布,但α2 则无此现象。此外,U18666A 导致α1 向晚期内体/溶酶体再分布,而蛋白酶体抑制剂则阻止了 U18666A 引起的α1 减少。这些结果表明,胆固醇对 Na/K-ATPaseα 亚基的调节是同工型特异的,而α1 则通过内吞体-蛋白酶体途径在这种调节中具有独特性。在机制上,A425Pα1 中Src 结合缺失突变丧失了受胆固醇调节的能力。同时,α2 中的Src 结合获得性突变部分恢复了调节作用。此外,通过对窖蛋白-1 敲低细胞的研究以及不同α-同工型细胞系的亚细胞分布研究,我们发现 Na/K-ATPase、Src 和窖蛋白-1 共同作用于胆固醇调节。总之,这些新发现揭示了假定的 Src 结合结构域和完整的 Na/K-ATPase/Src/窖蛋白-1 复合物对于胆固醇对 Na/K-ATPase 的同工型特异性调节是必不可少的。